These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38392905)

  • 1. Preservation of scRNA-Seq Libraries Using Existing Inactivation Protocols.
    Sturdevant GL; Meade-White KD; Best SM; Speranza E
    Pathogens; 2024 Feb; 13(2):. PubMed ID: 38392905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment of an Inactivation Method for Ebola Virus and SARS-CoV-2 Suitable for Downstream Sequencing of Low Cell Numbers.
    Olejnik J; Leon J; Michelson D; Chowdhary K; Galvan-Pena S; Benoist C; Mühlberger E; Hume AJ
    Pathogens; 2023 Feb; 12(2):. PubMed ID: 36839614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heat Inactivation of Nipah Virus for Downstream Single-Cell RNA Sequencing Does Not Interfere with Sample Quality.
    Hume AJ; Olejnik J; White MR; Huang J; Turcinovic J; Heiden B; Bawa PS; Williams CJ; Gorham NG; Alekseyev YO; Connor JH; Kotton DN; Mühlberger E
    Pathogens; 2024 Jan; 13(1):. PubMed ID: 38251369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Art of the Kill: Designing and Testing Viral Inactivation Procedures for Highly Pathogenic Negative Sense RNA Viruses.
    Olejnik J; Hume AJ; Ross SJ; Scoon WA; Seitz S; White MR; Slutzky B; Yun NE; Mühlberger E
    Pathogens; 2023 Jul; 12(7):. PubMed ID: 37513799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Planning Implications Related to Sterilization-Sensitive Science Investigations Associated with Mars Sample Return (MSR).
    Velbel MA; Cockell CS; Glavin DP; Marty B; Regberg AB; Smith AL; Tosca NJ; Wadhwa M; Kminek G; Meyer MA; Beaty DW; Carrier BL; Haltigin T; Hays LE; Agee CB; Busemann H; Cavalazzi B; Debaille V; Grady MM; Hauber E; Hutzler A; McCubbin FM; Pratt LM; Smith CL; Summons RE; Swindle TD; Tait KT; Udry A; Usui T; Westall F; Zorzano MP
    Astrobiology; 2022 Jun; 22(S1):S112-S164. PubMed ID: 34904892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Universal Next-Generation Sequencing Protocol To Generate Noninfectious Barcoded cDNA Libraries from High-Containment RNA Viruses.
    Moser LA; Ramirez-Carvajal L; Puri V; Pauszek SJ; Matthews K; Dilley KA; Mullan C; McGraw J; Khayat M; Beeri K; Yee A; Dugan V; Heise MT; Frieman MB; Rodriguez LL; Bernard KA; Wentworth DE; Stockwell TB; Shabman RS
    mSystems; 2016; 1(3):. PubMed ID: 27822536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient inactivation of Burkholderia pseudomallei or Francisella tularensis in infected cells for safe removal from biosafety level 3 containment laboratories.
    Emery FD; Stabenow JM; Miller MA
    Pathog Dis; 2014 Jul; 71(2):276-81. PubMed ID: 24449562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inactivation of RNA Viruses by Gamma Irradiation: A Study on Mitigating Factors.
    Hume AJ; Ames J; Rennick LJ; Duprex WP; Marzi A; Tonkiss J; Mühlberger E
    Viruses; 2016 Jul; 8(7):. PubMed ID: 27455307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inactivation Methods for Experimental Nipah Virus Infection.
    Widerspick L; Vázquez CA; Niemetz L; Heung M; Olal C; Bencsik A; Henkel C; Pfister A; Brunetti JE; Kucinskaite-Kodze I; Lawrence P; Muñoz Fontela C; Diederich S; Escudero-Pérez B
    Viruses; 2022 May; 14(5):. PubMed ID: 35632791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inactivation and safety testing of Middle East Respiratory Syndrome Coronavirus.
    Kumar M; Mazur S; Ork BL; Postnikova E; Hensley LE; Jahrling PB; Johnson R; Holbrook MR
    J Virol Methods; 2015 Oct; 223():13-8. PubMed ID: 26190637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A BSL-4 high-throughput screen identifies sulfonamide inhibitors of Nipah virus.
    Tigabu B; Rasmussen L; White EL; Tower N; Saeed M; Bukreyev A; Rockx B; LeDuc JW; Noah JW
    Assay Drug Dev Technol; 2014 Apr; 12(3):155-61. PubMed ID: 24735442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A rapid Orthopoxvirus purification protocol suitable for high-containment laboratories.
    Hughes L; Wilkins K; Goldsmith CS; Smith S; Hudson P; Patel N; Karem K; Damon I; Li Y; Olson VA; Satheshkumar PS
    J Virol Methods; 2017 May; 243():68-73. PubMed ID: 28131867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Introduction of high containment laboratories in abroad].
    Furuyama W; Nanbo A
    Uirusu; 2022; 72(2):139-148. PubMed ID: 38220158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety Precautions and Operating Procedures in an (A)BSL-4 Laboratory: 1. Biosafety Level 4 Suit Laboratory Suite Entry and Exit Procedures.
    Janosko K; Holbrook MR; Adams R; Barr J; Bollinger L; Newton JT; Ntiforo C; Coe L; Wada J; Pusl D; Jahrling PB; Kuhn JH; Lackemeyer MG
    J Vis Exp; 2016 Oct; (116):. PubMed ID: 27768063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validating the Inactivation Effectiveness of Chemicals on Ebola Virus.
    Haddock E; Feldmann F
    Methods Mol Biol; 2017; 1628():251-257. PubMed ID: 28573626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of inactivation procedures for SARS-CoV-2.
    Auerswald H; Yann S; Dul S; In S; Dussart P; Martin NJ; Karlsson EA; Garcia-Rivera JA
    J Gen Virol; 2021 Mar; 102(3):. PubMed ID: 33416462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biosafety Recommendations for Work with Influenza Viruses Containing a Hemagglutinin from the A/goose/Guangdong/1/96 Lineage.
    ; Gangadharan D; Smith J; Weyant R
    MMWR Recomm Rep; 2013 Jun; 62(RR-06):1-7. PubMed ID: 23803973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactivation efficacy of H5N1 avian influenza virus by commonly used sample preparation reagents for safe laboratory practices.
    Avelin V; Sissonen S; Julkunen I; Österlund P
    J Virol Methods; 2022 Jun; 304():114527. PubMed ID: 35354068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [BSL-4 facility and New virus research in Japan].
    Yasuda J
    Uirusu; 2022; 72(1):1-6. PubMed ID: 37899225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Buffer AVL Alone Does Not Inactivate Ebola Virus in a Representative Clinical Sample Type.
    Smither SJ; Weller SA; Phelps A; Eastaugh L; Ngugi S; O'Brien LM; Steward J; Lonsdale SG; Lever MS
    J Clin Microbiol; 2015 Oct; 53(10):3148-54. PubMed ID: 26179307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.